Whalesbook
SEBI Approves IPOs for Deepa Jewellers and Cotec Healthcare
India's Securities and Exchange Board of India (SEBI) has given the go-ahead for the Initial Public Offerings (IPOs) of Deepa Jewellers and Cotec Healthcare, clearing a major hurdle for both companies.
Deepa Jewellers Eyes Rs 250 Crore Raise
Telangana-based Deepa Jewellers plans to raise Rs 250 crore through its IPO. The company intends to allocate Rs 215 crore of the proceeds towards long-term working capital needs and general corporate purposes. The approval follows the filing of its draft red herring prospectus in December 2025, with SEBI issuing observations on May 18.
Cotec Healthcare Seeks Rs 295 Crore for Expansion
Cotec Healthcare, an Uttarakhand-based contract development and manufacturing organization (CDMO), aims to raise Rs 295 crore. A significant portion of these funds will be used to establish new manufacturing capacities and support product development initiatives. Cotec Healthcare filed its draft red herring prospectus in September 2025 and received SEBI's observations on May 18.
Market and Investor Considerations
Deepa Jewellers operates in India's large, traditionally fragmented jewelry sector. Investors will consider its competitive position against national brands and local players, and its reliance on working capital which suggests sensitivity to inventory and seasonal demand.
Cotec Healthcare, as a CDMO, is positioned in a growing pharmaceutical outsourcing market. Its planned capacity expansion is a strategic move, but the company faces increasing competition. Investors will need to evaluate the sufficiency of the fundraising for scalable growth and margin sustainability against larger competitors.
Potential Risks for Investors
Potential investors should note several risks. Deepa Jewellers' significant allocation to working capital could expose it to inventory obsolescence or receivables management issues, especially given gold demand's cyclical nature. An offer-for-sale component involving promoters selling shares may prompt questions about their commitment.
For Cotec Healthcare, expansion success depends on securing new contracts and managing increased operational complexity. The contract manufacturing sector can face pricing pressures and client loss risks, impacting revenue stability. Both companies also operate in sectors with evolving regulations and potential supply chain vulnerabilities.
Path to Public Markets
With SEBI's approval, both Deepa Jewellers and Cotec Healthcare can now file their final Red Herring Prospectuses. Their success in the public markets will depend on investor appetite and their ability to present a clear growth strategy. Post-listing performance will be key to assessing capital deployment and their ability to navigate competitive and regulatory landscapes.